Examkin

Question

Difficulty: Very hardGeneral Internal Medicine

The nursing staff urgently requests an evaluation of a 6464-year-old man in the pulmonary step-down unit due to decreasing responsiveness. The patient was admitted 3636 hours ago for a severe exacerbation of chronic obstructive pulmonary disease (COPD). His initial treatment included intravenous methylprednisolone, nebulized ipratropium-albuterol, oral doxycycline, and supplemental oxygen. Over the past 1212 hours, his oxygen delivery was escalated to a non-rebreather mask by the cross-cover team due to perceived hypoxemia. His other medical history includes systemic hypertension, diet-controlled type 2 diabetes, and osteoarthritis.

Vital signs are:
Temperature: 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F})
Blood pressure: 142/86 mm Hg142/86 \text{ mm Hg}
Heart rate: 108/min108/\text{min}
Respiratory rate: 8/min8/\text{min}
Pulse oximetry: 99%99\% on the non-rebreather mask

On physical examination, the patient is lethargic but opens his eyes and follows simple commands when spoken to loudly. Noticeable asterixis is present on bilateral wrist extension. The jugular venous pressure is visually estimated at 5 cm H2O5 \text{ cm H}_2\text{O}. Auscultation of the chest reveals a markedly prolonged expiratory phase with faint, diffuse wheezing, but no crackles. The cardiac rhythm is regular. Trace bilateral pedal edema is noted.

Relevant morning laboratory panels show:
Leukocytes: 8,200/mm38,200/\text{mm}^3
Sodium: 138 mEq/L138 \text{ mEq/L}
Potassium: 4.3 mEq/L4.3 \text{ mEq/L}
Chloride: 94 mEq/L94 \text{ mEq/L}
Bicarbonate: 36 mEq/L36 \text{ mEq/L}
Thyroid-stimulating hormone (TSH): 0.1μU/mL0.1 \mu\text{U/mL} (Normal: 0.4−4.0μU/mL0.4-4.0 \mu\text{U/mL})
Free thyroxine (T4): 1.2 ng/dL1.2 \text{ ng/dL} (Normal: 0.9−1.7 ng/dL0.9-1.7 \text{ ng/dL})

An arterial blood gas analysis drawn on his current oxygen support demonstrates:
pH: 7.207.20
PaCO2PaCO_2: 95 mm Hg95 \text{ mm Hg}
PaO2PaO_2: 148 mm Hg148 \text{ mm Hg}

Based on these clinical and laboratory findings, which of the following is the most appropriate next step in management?

  1. A
    Administer intravenous sodium bicarbonate to correct the severe acidemia
  2. B
    Discontinue doxycycline and initiate empiric intravenous vancomycin and cefepime
  3. Transition to noninvasive positive-pressure ventilation and titrate oxygen to target a saturation of 88% to 92%Answer
  4. D
    Administer intravenous furosemide and obtain an urgent echocardiogram
  5. E
    Administer intravenous levothyroxine for acute central hypothyroidism

Answer

Transition to noninvasive positive-pressure ventilation and titrate oxygen to target a saturation of 88% to 92%
The correct answer involves treating the patient's oxygen-induced hypercapnia. Patients with severe COPD rely on hypoxic pulmonary vasoconstriction to optimize V/Q matching. Administering excessive high-flow oxygen (resulting in a PaO2PaO_2 of 148 mm Hg148 \text{ mm Hg}) reverses this vasoconstriction, increasing dead space ventilation. Furthermore, high O2O_2 levels decrease the affinity of hemoglobin for CO2CO_2 (Haldane effect), leading to a massive spike in PaCO2PaCO_2 (95 mm Hg95 \text{ mm Hg}) and subsequent CO2CO_2 narcosis (evidenced by somnolence and asterixis). The appropriate management is to transition to noninvasive positive-pressure ventilation (to actively clear CO2CO_2 and support respiratory mechanics) and to strictly titrate oxygen delivery to a target saturation of 88%−92%88\%-92\% to prevent recurrent hypercapnia.

Step-by-Step Solution

1
Analyze the patient's arterial blood gas and physical exam to identify the primary pathophysiologic insult.
The ABG shows a severe acute-on-chronic respiratory acidosis (pH 7.207.20, PaCO2PaCO_2 95 mm Hg95 \text{ mm Hg}) and hyperoxia (PaO2PaO_2 148 mm Hg148 \text{ mm Hg}). The patient has classic signs of CO2CO_2 narcosis (somnolence, asterixis, hypoventilation).
Understanding the primary disturbance is required before selecting an intervention.
2
Correlate the findings with the recent management changes.
The escalation to a non-rebreather mask caused the hyperoxia, which abolished hypoxic pulmonary vasoconstriction, worsened V/Q mismatch, and led to the massive retention of CO2CO_2.
Identifying the iatrogenic cause dictates the corrective action.
3
Evaluate the distractor presentations (cardiac, infectious, endocrine, metabolic).
The absence of crackles and normal JVP rules out heart failure. The lack of fever or leukocytosis rules out new sepsis. The TSH/T4 pattern represents medication-induced suppression (steroids), not hypothyroidism. The high bicarbonate represents chronic metabolic compensation for his baseline COPD, not an indication for sodium bicarbonate.
Systematically ruling out competing diagnoses prevents premature closure and selection of incorrect, harmful therapies.
4
Determine the most appropriate next step in management.
Remove the non-rebreather mask, apply noninvasive positive-pressure ventilation (NPPV) to assist with CO2CO_2 clearance, and titrate oxygen to target a safe saturation of 88%−92%88\%-92\%.
This directly treats both the iatrogenic cause and the life-threatening respiratory failure without resorting to premature intubation.

Key Concept

Diagnosis and management of oxygen-induced hypercapnia in chronic obstructive pulmonary disease
Rate this question

Topics

General Internal Medicine

More questions from this topic